Administrator

0 Comments
Tim Seymour, the founder and chief investment officer of Seymour Asset Management and the man behind the Amplify Seymour Cannabis ETF (CNBS), runs through three major headlines moving cannabis stocks. Subscribe to CNBC Pro to access our live Pro Talk “How to Navigate the Reddit Market Mania” with Fundstrat’s Tom Lee and CNBC’s Mike Santoli:
0 Comments
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest
0 Comments
The hemp industry has high hopes for thriving under President Joe Biden, with operators seeing opportunities in the president’s climate plan and feeling optimistic that congressional action on high-THC cannabis will open more opportunities for hemp entrepreneurs. But the industry is still waiting for answers on some of its most pressing concerns, especially the legality
0 Comments
A former federal prosecutor in western Kentucky has re-joined the U.S. Hemp Roundtable to lead efforts to cooperate with law enforcement. Russell Coleman was appointed by former President Donald Trump as U.S. Attorney for the Western District of Kentucky. He served from 2017 until Jan. 20, resigning when President Joe Biden was inaugurated. The U.S.